Learning Objectives:

1. To understand the complicated history of controlled human infection, or challenge, studies.

2. To be able to identify salient ethical considerations for controlled human infection studies.

3. To be able to articulate potential ethically acceptable conditions and uses for controlled human infection studies to address COVID-19.

Session date: 
Wednesday, February 24, 2021 - 12:00pm to 1:30pm
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Please login or create an account to proceed.
Speaker Name: 
Seema Shah, JD